Daratumumab,Talquetamab,Teclistamab,Pomalidomide
Genmab,Janssen
['mmsm', 'thanks', 'janssen']
 and thanks for your never ending research #asco2023 this bispecific, with a non-bcma target, will save and extend #mmsm lives. 
Myeloma since 1997. Retired from Family Practice after SCT. Cancer research advocate with NCI, Alliance, CIBMTR, FDA, many other areas.